| |
| |
|
| Insider
Information: |
Horton Kenneth L |
| Relationship: |
GC & Corp. Development... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,019,239 |
|
|
Indirect Shares
|
366 |
|
|
| Direct
Value |
$29,882,151 |
|
|
|
Indirect Value
|
$146,795 |
|
|
| Total
Shares |
2,019,605 |
|
|
| Total
Value |
$30,028,947 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -52.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP & Chief Legal Offi... |
2014-11-17 |
72,053 |
2014-11-17 |
366 |
Premium* |
|
|
Senseonics Holdings Inc |
SENS |
GC & Corp. Development... |
2023-11-15 |
1,947,186 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2023-11-15 |
4 |
D |
$0.61 |
$99,625 |
D/D |
(163,319) |
1,947,186 |
0 |
- |
|
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2023-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
782,089 |
2,161,781 |
0 |
- |
|
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2023-05-15 |
4 |
D |
$0.74 |
$102,066 |
D/D |
(137,927) |
1,379,692 |
0 |
- |
|
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2022-11-15 |
4 |
D |
$1.25 |
$130,383 |
D/D |
(104,306) |
1,517,619 |
0 |
- |
|
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2022-06-15 |
4 |
D |
$0.97 |
$25,322 |
D/D |
(26,105) |
1,621,925 |
0 |
- |
|
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
476,035 |
1,648,030 |
0 |
- |
|
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2022-05-16 |
4 |
D |
$1.13 |
$51,336 |
D/D |
(45,430) |
1,171,995 |
0 |
- |
|
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2022-02-11 |
4 |
S |
$2.46 |
$352,090 |
D/D |
(143,126) |
1,217,425 |
0 |
% |
|
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
255,287 |
1,360,551 |
0 |
- |
|
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2021-11-15 |
4 |
D |
$3.80 |
$176,419 |
D/D |
(46,426) |
1,105,264 |
0 |
- |
|
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
306,451 |
1,162,589 |
0 |
- |
|
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2021-05-15 |
4 |
D |
$1.92 |
$66,643 |
D/D |
(34,710) |
856,138 |
0 |
- |
|
| SENS |
Senseonics Holdings Inc |
GC & Corp. Development Advisor |
• – – |
2021-03-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
925,379 |
|
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Legal Officer |
• – – |
2014-11-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
410 |
72,053 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Legal Officer |
• – – |
2014-10-30 |
4 |
A |
$0.01 |
$400 |
D/D |
40,000 |
72,463 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Legal Officer |
• – – |
2014-09-30 |
4 |
AS |
$111.33 |
$4,056,680 |
D/D |
(36,000) |
32,463 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Legal Officer |
• – – |
2014-09-30 |
4 |
OE |
$55.83 |
$2,009,880 |
D/D |
36,000 |
68,463 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Legal Officer |
• – – |
2014-07-01 |
4 |
OE |
$45.11 |
$1,277,560 |
D/D |
28,321 |
62,597 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Legal Officer |
• – – |
2014-07-01 |
4 |
AS |
$94.49 |
$2,869,384 |
D/D |
(30,134) |
32,463 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Legal Officer |
• – – |
2014-02-05 |
4 |
A |
$0.01 |
$173 |
D/D |
17,250 |
33,874 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Legal Officer |
• – – |
2013-12-12 |
4 |
AS |
$65.46 |
$296,665 |
D/D |
(4,532) |
16,624 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Legal Officer |
• – – |
2013-07-08 |
4 |
AS |
$80.50 |
$146,343 |
D/D |
(1,813) |
20,676 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Legal Officer |
• – – |
2013-02-05 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
21,751 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Legal Officer |
• – – |
2012-06-11 |
4 |
A |
$0.01 |
$97 |
D/D |
9,667 |
9,667 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
